Kinetic Analysis of the Early Signaling Steps of the Human Chemokine Receptor CXCR4

被引:12
|
作者
Perpina-Viciano, Cristina [1 ,2 ]
Isbilir, Ali [2 ,3 ]
Zarca, Aurelien [4 ]
Caspar, Birgit [5 ,6 ,7 ]
Kilpatrick, Laura E. [5 ,6 ,7 ]
Hill, Stephen J. [5 ,6 ,7 ]
Smit, Martine J. [4 ]
Lohse, Martin J. [2 ,3 ]
Hoffmann, Carsten [1 ,2 ]
机构
[1] Univ Jena, Univ Hosp Jena, Inst Mol Cell Biol, Ctr Mol Biomed CMB, Hans Knoll Str 2, D-07745 Jena, Germany
[2] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany
[3] Max Delbruck Ctr Mol Med, Berlin, Germany
[4] Vrije Univ, Amsterdam Inst Mol Med & Syst AIMMS, Div Med Chem, Amsterdam, Netherlands
[5] Univ Nottingham, Queens Med Ctr, Med Sch, Div Physiol Pharmacol & Neurosci,Sch Life Sci, Nottingham, England
[6] Univ Birmingham, Ctr Membrane Prot & Receptors Compare, The Midlands, England
[7] Univ Nottingham, The Midlands, England
基金
英国医学研究理事会; 欧盟地平线“2020”;
关键词
PROTEIN-COUPLED RECEPTOR; PARATHYROID-HORMONE RECEPTOR; CRYSTAL-STRUCTURE; RESIDENCE TIME; SMALL-MOLECULE; ACTIVATION; GPCR; MIGRATION; CANCER; LIGAND;
D O I
10.1124/mol.119.118448
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
G protein-coupled receptors (GPCRs) are biologic switches that transduce extracellular stimuli into intracellular responses in the cell. Temporally resolving GPCR transduction pathways is key to understanding how cell signaling occurs. Here, we investigate the kinetics and dynamics of the activation and early signaling steps of the CXC chemokine receptor (CXCR) 4 in response to its natural ligands CXC chemokine ligand (CXCL) 12 and macrophage migration inhibitory factor (MIF), using Forster resonance energy transfer-based approaches. We show that CXCR4 presents a multifaceted response to CXCL12, with receptor activation (approximate to 0.6 seconds) followed by a rearrangement in the receptor/G protein complex (approximate to 1 seconds), a slower dimer rearrangement (approximate to 1.7 seconds), and prolonged G protein activation (RA seconds). In comparison, MIF distinctly modulates every step of the transduction pathway, indicating distinct activation mechanisms and reflecting the different pharmacological properties of these two ligands. Our study also indicates that CXCR4 exhibits some degree of ligand-independent activity, a relevant feature for drug development. SIGNIFICANCE STATEMENT The CXC chemokine ligand (CXCL) 12/CXC chemokine receptor (CXCR) 4 axis represents a well-established therapeutic target for cancer treatment. We demonstrate that CXCR4 exhibits a multifaceted response that involves dynamic receptor dimer rearrangements and that is kinetically embedded between receptor-G protein complex rearrangements and G protein activation. The alternative endogenous ligand macrophage migration inhibitory factor behaves opposite to CXCL12 in each assay studied and does not lead to G protein activation. This detailed understanding of the receptor activation may aid in the development of more specific drugs against this target.
引用
收藏
页码:72 / 87
页数:16
相关论文
共 50 条
  • [21] The role of chemokine receptor CXCR4 in lung cancer
    Gangadhar, Tara
    Nandi, Suvobroto
    Salgia, Ravi
    [J]. CANCER BIOLOGY & THERAPY, 2010, 9 (06)
  • [22] The dynamics of chemokine receptor CXCR4 endocytosis.
    Rosselli-Murai, L. K.
    DeNies, M.
    White, M.
    Liu, A. P.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [23] Chemokine receptor CXCR4: Role in gastrointestinal cancer
    Lombardi, Lucia
    Tavano, Francesca
    Morelli, Franco
    Latiano, Tiziana Pia
    Di Sebastiano, Pierluigi
    Maiello, Evaristo
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 (03) : 696 - 705
  • [24] Role of the chemokine receptor CXCR4 in Waldenstrom Macroglobulinemia
    Ghobrial, IM
    Melhem, M
    Singha, U
    George, D
    Timm, M
    Francis, L
    Alsayed, Y
    Huston, A
    Roodman, GD
    Greipp, P
    Gertz, M
    Witzig, T
    [J]. BLOOD, 2005, 106 (11) : 291A - 292A
  • [25] The good and bad faces of the CXCR4 chemokine receptor
    Teixido, Joaquin
    Martinez-Moreno, Monica
    Diaz-Martinez, Marta
    Sevilla-Movilla, Silvia
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 95 : 121 - 131
  • [26] The chemokine receptor CXCR4 in cerebellar development and medulloblastoma
    Ghatan, S.
    Hirsh, B.
    Gattis, S.
    Cannoll, P.
    Garvin, J. H.
    [J]. NEURO-ONCOLOGY, 2007, 9 (02) : 184 - 184
  • [27] Lessons from the structure of the chemokine receptor, CXCR4
    Qin, Ling
    Kufareva, Irina
    Wang, Chong
    Wu, Huixian
    Stephens, Bryan
    Holden, Lauren
    Wu, Beili
    Fenalti, Gus
    Cherezov, Vadim
    Stevens, Ray
    Abagyan, Ruben
    Handel, Tracy
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [28] CXCR4 chemokine receptor antagonists: perspectives in SCLC
    Burger, Jan A.
    Stewart, David J.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (04) : 481 - 490
  • [29] CXCR4 CHEMOKINE RECEPTOR SIGNALING MEDIATES PAIN HYPERSENSITIVITY IN PAINFUL DIABETIC NEUROPATHY
    Menichella, D. M.
    Ren, D.
    Belmadani, A.
    Shum, A.
    Bhattacharyya, B.
    Miller, R.
    [J]. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 : 72 - 72
  • [30] Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses
    Willett, BJ
    Picard, L
    Hosie, MJ
    Turner, JD
    Adema, K
    Clapham, PR
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (09) : 6407 - 6415